**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 105-36-2 |Ethyl Bromoacetate | 98% | 203-290-9 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: T+
Risk Phrases: 26/27/28
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Very toxic by inhalation, in contact with skin and if
swallowed.Lachrymator (substance which increases the flow of
tears).The toxicological properties of this material have not been
fully investigated.
Potential Health Effects
Eye:
Causes severe eye irritation. May cause opacity and scarring.
Lachrymator (substance which increases the flow of tears).
Skin:
Causes severe skin irritation. May be absorbed through the skin.
Ingestion:
Causes gastrointestinal irritation with nausea, vomiting and
diarrhea.
Inhalation:
May cause respiratory tract irritation. Vapors may cause dizziness
or suffocation.
Chronic:
Not available.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid
immediately.
Skin:
Get medical aid immediately. Flush skin with plenty of water for at
least 15 minutes while removing contaminated clothing and shoes.
Wash clothing before reuse.
Ingestion:
If victim is conscious and alert, give 2-4 cupfuls of milk or water.
Never give anything by mouth to an unconscious person. Get medical
aid immediately.
Inhalation:
Get medical aid immediately. Remove from exposure and move to fresh
air immediately. If not breathing, give artificial respiration. If
breathing is difficult, give oxygen.
Notes to Physician:
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. Vapors may form an explosive mixture with air.
Vapors can travel to a source of ignition and flash back. Flammable
liquid and vapor. Vapors may be heavier than air. They can spread
along the ground and collect in low or confined areas.
Extinguishing Media:
Use water fog, dry chemical, carbon dioxide or alcohol type foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth),
then place in suitable container. Remove all sources of ignition.
Use a spark-proof tool. Provide ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Remove contaminated clothing and
wash before reuse. Use only in a well-ventilated area. Ground and
bond containers when transferring material. Use spark-proof tools and
explosion proof equipment. Avoid contact with eyes, skin, and
clothing. Empty containers retain product residue, (liquid and/or
vapor), and can be dangerous. Avoid ingestion and inhalation. Do not
pressurize, cut, weld, braze, solder, drill, grind, or expose empty
containers to heat, sparks or open flames.
Storage:
Keep away from heat, sparks, and flame. Keep away from sources of
ignition. Keep container closed when not in use. Store in a cool,
dry, well-ventilated area away from incompatible substances.
Flammables-area.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Use adequate ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 105-36-2:
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Use a
NIOSH/MSHA or European Standard EN 149 approved
respirator if exposure limits are exceeded or if
irritation or other symptoms are experienced.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Liquid
Color: clear, colorless
Odor: Not available.
pH: Not available.
Vapor Pressure: 2.6 mm Hg @ 25 deg
Viscosity: Not available.
Boiling Point: 159 deg C @ 760.00mm Hg
Freezing/Melting Point: -38 deg C
Autoignition Temperature: Not available.
Flash Point: 47 deg C ( 116.60 deg F)
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water: Insoluble.
Specific Gravity/Density: 1.5060g/cm3
Molecular Formula: C4H7BrO2
Molecular Weight: 167.00
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, ignition sources, excess heat, electrical
sparks, exposure to flame.
Incompatibilities with Other Materials:
Oxidizing agents, reducing agents, acids, bases.
Hazardous Decomposition Products:
Carbon monoxide, carbon dioxide, hydrogen bromide.
Hazardous Polymerization: Has not been reported.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 105-36-2: AF6000000
LD50/LC50:
Not available.
Carcinogenicity:
Ethyl Bromoacetate -
Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Shipping Name: ETHYL BROMOACETATE
Hazard Class: 6.1 (3)
UN Number: 1603
Packing Group:
IMO
Shipping Name: ETHYL BROMOACETATE
Hazard Class: 6.1 (3)
UN Number: 1603
Packing Group: II
RID/ADR
Shipping Name: ETHYL BROMOACETATE
Hazard Class: 6.1
UN Number: 1603
Packing group: II
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: T+
Risk Phrases:
R 26/27/28 Very toxic by inhalation, in contact with
skin and if swallowed.
Safety Phrases:
S 7/9 Keep container tightly closed and in a
well-ventilated place.
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 105-36-2: No information available.
Canada
CAS# 105-36-2 is listed on Canada's DSL List.
CAS# 105-36-2 is listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 105-36-2 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 5/01/1998 Revision #2 Date: 3/18/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
2-(4-Phenoxyphenyl)-1-phenyl-1-ethanone, 95+%
| 27798-40-9 |
|
1-Cyclohexyl-2-phenyl-1-ethanone, 95+%
| 61259-29-8 |
|
Diacetyl Monoxime
| 57-71-6 |
|
Dimethylglyoxime
| 95-45-4 |
|
2-Deoxy-D-Galactose, 99%
| 1949-89-9 |
|
3-N-butoxypropylamine, 98+%
| 16494-24-9 |
|
Brilliant Blue R
| 6104-59-2 |
|
N-Methyl-3-(3-methyl[1,2,4]triazolo[4,3-b]pyridazin-6-yl)aniline, 97%
| 108810-87-3 |
|
Ethyl 2-(5-bromo-2-thienyl)-1,3-thiazole-4-carboxylate, tech
| 423768-45-0 |
|
2-Bromo-1-phenyl-1-ethanone oxime, 97%
| 14181-72-7 |
|
4-[(2,2-Dimethylpropanoyl)amino]nicotinic acid, 97%
| 125867-31-4 |
|
3-Amino-4-(methylamino)benzonitrile, 90+%
| 64910-46-9 |
|
Methyl 1h-benzimidazole-5-carboxylate, 97%
| 26663-77-4 |
|
3-(1,3-Oxazol-5-yl)benzenesulfonyl chloride, 90+%
| 499770-75-1 |
|
Ethyl 5-[4-(chlorosulfonyl)phenyl]-2-methyl-3-furoate, 90+%
| 499770-69-3 |
|
1-(4-Methoxyphenyl)-5-methyl-1h-pyrazole-4-carbaldehyde, 95+%
| 423768-44-9 |
|
1-(4-Fluorophenyl)-5-methyl-1h-pyrazole-4-carbaldehyde, 97%
| 423768-41-6 |
|
5-Methyl-1-(2-methylphenyl)-1H-pyrazole-4-carbonyl chloride, 97%
| 423768-42-7 |
|
5-Methyl-1-(2-methylphenyl)-1h-pyrazole-4-carbaldehyde, 97%
| 423768-40-5 |
|
4-(4-Chlorophenyl)-1,2,3-thiadiazol-5-amine, 97%
| 388088-77-5 |
|
1,3-Dimethyl-5-Nitrouracil Monohydrate
| 41613-26-7 |
|
4-(4-Methoxyphenyl)-1,2,3-thiadiazol-5-amine, 97%
| 115842-95-0 |
|
Ethyl Bromoacetate, 98% (GC)
| 105-36-2 |
|
4-Chlorofuro[3,2-c]pyridine, 95+%
| 31270-80-1 |
|
2-[3-Methyl-2-(methylimino)-4-oxo-1,3-thiazolan-5-yl]acetic acid, 97%
| 41306-29-0 |
|
1,2-Benzisoxazol-3-amine, 97%
| 36216-80-5 |
|
Diethylamine
| 109-89-7 |
|
4-Methoxy-1,2-benzisoxazol-3-amine, 97%
| 177995-40-3 |
|
Methyl 3-(chlorosulfonyl)-4-methoxybenzoate, 90+%
| 192323-12-9 |
|
4-Bromo-2-(trifluoromethyl)benzenesulfonyl chloride, 97%
| 176225-10-8 |
|
2-[(2,2-Dimethylpropanoyl)amino]nicotinic acid, 97%
| 125867-25-6 |
|
3-Fluoro-4-methylbenzenesulfonyl chloride, 97%
| 90260-13-2 |
|
4-(1,3-Dioxolan-2-yl)piperidine, 90+%
| 423768-60-9 |
|
3-(4-Fluorophenyl)-5-methyl-4-isoxazolecarboxylic acid, 97%
| 1736-21-6 |
|
1,3-Dimethyl-2-imidazolidinone, 98%
| 80-73-9 |
|
3-(4-Methoxyphenyl)-5-methyl-4-isoxazolecarboxylic acid, 97%
| 93041-45-3 |
|
3-(4-Fluorophenyl)-5-methyl-4-isoxazolecarbonyl chloride, 97%
| 465514-05-0 |
|
3-(4-Methoxyphenyl)-5-methyl-4-isoxazolecarbonyl chloride, 97%
| 465514-03-8 |
|
1-[3-Amino-4-(methylamino)phenyl]-1-ethanone, 97%
| 18076-19-2 |
|
4-(4-Chlorophenyl)cyclohexanecarbohydrazide, 95+%
| 368870-04-6 |
|
2,2-Dimethyl-6-chromanesulfonyl chloride, 97%
| 131880-55-2 |
|
2-Bromo-1-(3,5-dimethyl-1-benzothiophen-2-yl)-1-ethanone, 97%
| 388088-83-3 |
|
5-Methyl-1-(2-methylphenyl)-1h-pyrazole-4-carboxylic acid, 97%
| 423768-56-3 |
|
3-Chloro-1,2-benzisoxazole, 97%
| 16263-52-8 |
|
4-Bromo-Alpha, Alpha, Alpha,2,3,5,6-Heptafluorotoluene, 99%
| 17823-46-0 |
|
5-(4-Methoxyphenyl)-1,3-oxazole-4-carboxylic acid, 97%
| 89205-07-2 |
|
5-(4-Methoxyphenyl)-1,3-oxazole-4-carbonyl chloride, 97%
| 465514-15-2 |
|
1-[2-(2,5-Dimethyl-1h-pyrrol-1-yl)ethyl]piperazine, 90+%
| 5059-36-9 |
|
4-(Morpholine-4-sulfonyl)-benzenesulfonyl chloride, tech
| 465514-13-0 |
|
4-(Pyrrolidine-1-sulfonyl)-benzenesulfonyl chloride, tech
| 165669-32-9 |
|
|